Neuraminidase Activators comprise a collection of chemical compounds that can indirectly improve the catalytic efficiency of Neuraminidase, primarily through interactions with the enzyme's active site or substrate availability. Zanamivir, a neuraminidase inhibitor, binds to Neuraminidase's active site, causing structural changes that may enhance the enzyme's action on sialic acid residues. Similarly, Oseltamivir, after conversion to its active metabolite Oseltamivir carboxylate, and Peramivir, another competitive inhibitor, interact with Neuraminidase in a way that could allosterically promote sialic acid cleavage. Laninamivir and DANA (2,3-Dehydro-2-deoxy-N-acetylneuraminic acid), both sialic acid analogs, can increase the affinity and specificity of Neuraminidase for its natural substrates. Furthermore, the presence of high concentrations of sialic acid and its natural form, N-acetylneuraminic acid, as well as the precursor N-acetylmannosamine and the trisaccharide sialyllactose, provide abundant substrate, which through substrate-induced activation, can enhance the activity of Neuraminidase.
The activity of Neuraminidase is further influenced by Tamiflu, a prodrug that is metabolized to Oseltamivir carboxylate, functioning similarly to Oseltamivir by potentially increasing the enzyme's substrate cleavage efficiency. Additionally, synthetic sialic acid analogs, though not individually named, may serve as competitive substrates that enhance Neuraminidase activity by ensuring constant engagement of the enzyme with its substrates. Certain flavonoids, a diverse group of plant metabolites, can also enhance Neuraminidase activity through their interactions with the enzyme, possibly facilitating better substrate binding or altering the enzyme's kinetics. Collectively, these Neuraminidase activators, through binding interactions and substrate availability, function to enhance the enzymatic activity of Neuraminidase without directly upregulating its expression or modifying its gene, VCNA. These compounds ensure that Neuraminidase maintains a high level of functional activity, crucial for the hydrolysis of sialic acid residues from glycoproteins and glycolipids, a process essential for the viral replication cycle and the release of new viral particles from host cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zanamivir | 139110-80-8 | sc-208495 | 1 mg | $270.00 | 6 | |
This neuraminidase inhibitor binds to the active site of Neuraminidase, causing a conformational change that enhances its catalytic action on sialic acid residues. | ||||||
Oseltamivir | 196618-13-0 | sc-507283 | 100 g | $324.00 | ||
Oseltamivir is metabolized into its active form, Oseltamivir carboxylate, which interacts with Neuraminidase, leading to an indirect increase in its sialic acid cleavage activity. | ||||||
Peramivir | 330600-85-6 | sc-478569 | 1 mg | $317.00 | ||
Peramivir acts as a competitive inhibitor for Neuraminidase, which can result in an allosteric effect, enhancing the enzymatic cleavage of sialic acids from glycoproteins. | ||||||
Laninamivir | 203120-17-6 | sc-488700 sc-488700A sc-488700B sc-488700C sc-488700D sc-488700E | 500 µg 5 mg 50 mg 100 mg 250 mg 1 g | $411.00 $2710.00 $18212.00 $27417.00 $41101.00 $70752.00 | ||
Laninamivir binds to Neuraminidase, inducing a structural alteration that can increase the enzyme's affinity for sialic acid substrates. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
2,3-Dehydro-2-deoxy-N-acetylneuraminic acid (DANA) is a sialic acid analog that competitively inhibits Neuraminidase, potentially enhancing its substrate specificity and activity. | ||||||
N-Acetylneuraminic acid | 131-48-6 | sc-281055A sc-281055 sc-281055D sc-281055B sc-281055C | 1 g 5 g 25 g 100 g 250 g | $84.00 $156.00 $326.00 $572.00 $1363.00 | ||
As a substrate of Neuraminidase, high concentrations of sialic acid can promote enzyme activity through substrate-induced activation mechanisms. | ||||||
Oseltamivir phosphate | 204255-11-8 | sc-208135 sc-208135A | 10 mg 200 mg | $179.00 $650.00 | 5 | |
Tamiflu is a prodrug that is metabolized to Oseltamivir carboxylate, which can indirectly enhance Neuraminidase activity through competitive inhibition. | ||||||